Beyond Air (XAIR) Capital Expenditures Growth (3y) (2020 - 2026)
Analysis
Beyond Air (XAIR) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -0.66% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | -14.20% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 12.42% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 9.94% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 10.89% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 11.78% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 6.38% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 12.81% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 9.52% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | -23.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.14% |
| Mar 31, 2026 | -35.33% |
| Dec 31, 2025 | -62.29% |
| Sep 30, 2025 | -36.55% |
| Jun 30, 2025 | -8.45% |
| Mar 31, 2025 | 63.62% |
| Dec 31, 2024 | 8.62% |
| Sep 30, 2024 | 25.67% |
| Jun 30, 2024 | 362.61% |
| Mar 31, 2024 | 358.76% |
| Dec 31, 2023 | 112.67% |
| Sep 30, 2023 | 51.11% |
| Jun 30, 2023 | 48.35% |
| Mar 31, 2023 | 408.45% |
| Dec 31, 2022 | 292.16% |
| Sep 30, 2022 | 303.82% |
| Jun 30, 2022 | 336.04% |
| Mar 31, 2022 | 332.89% |
| Dec 31, 2021 | 198.38% |
| Mar 31, 2021 | 171.44% |